Stock Movers cover image

KB Homes Down, Arm to Sell Its Own Chips, ImmunityBio Plunges

Stock Movers

00:00

ImmunityBio Faces FDA Warning Letter

Avalon Purnell describes ImmunityBio's 21% plunge after an FDA letter over misleading promotion of its bladder cancer drug Anktiva.

Play episode from 03:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app